
Sign up to save your podcasts
Or


Isan Chen, CEO of MBrace Therapeutics, speaks with Venrock partner Racquel Bracken to discuss his career trajectory leading up to his founding of MBrace. Chen shares the impetus behind his decision to become an oncologist, why he switched from academic medicine to the industry side, lessons learned from years in drug development and more.
By Venrock, a venture capital firm4.8
6262 ratings
Isan Chen, CEO of MBrace Therapeutics, speaks with Venrock partner Racquel Bracken to discuss his career trajectory leading up to his founding of MBrace. Chen shares the impetus behind his decision to become an oncologist, why he switched from academic medicine to the industry side, lessons learned from years in drug development and more.

1,282 Listeners

2,705 Listeners

2,460 Listeners

1,099 Listeners

339 Listeners

323 Listeners

389 Listeners

5,554 Listeners

10,051 Listeners

34 Listeners

530 Listeners

21 Listeners

291 Listeners

473 Listeners

1,424 Listeners